Capital Performance Advisors LLP Pfizer Inc Transaction History
Capital Performance Advisors LLP
- $449 Million
- Q1 2025
A detailed history of Capital Performance Advisors LLP transactions in Pfizer Inc stock. As of the latest transaction made, Capital Performance Advisors LLP holds 13,139 shares of PFE stock, worth $306,795. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,139
Previous 20,507
35.93%
Holding current value
$306,795
Previous $544,000
38.97%
% of portfolio
0.07%
Previous 0.18%
Shares
8 transactions
Others Institutions Holding PFE
# of Institutions
3,369Shares Held
3.61BCall Options Held
102MPut Options Held
130M-
Vanguard Group Inc Valley Forge, PA523MShares$12.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$9.91 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$6.93 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$2.93 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.42 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $131B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...